Conventional continuous ambulatory peritoneal dialysis (CAPD) in patients without residual renal function and with high solute transport is associated with worse clinical outcomes. Automated peritoneal dialysis (APD) has the potential to improve both solute clearance and ultrafiltration in these circumstances, but its efficacy as a treatment modality is unknown. The European Automated Peritoneal Dialysis Outcomes Study (EAPOS) is a 2-year, prospective, European multi-center study designed to determine APD feasibility and clinical outcomes in anuric patients. The present article describes the baseline data for patients recruited into the study.
♦ Design
All PD patients treated in the participating centers were screened for inclusion criteria [urinary output < 100 mL/24 h, or residual renal function (RRF) < 1 mL/min, or both]. After enrollment, changes were made to the dialysis prescription to achieve a weekly creatinine clearance above 60 L per 1.73 m2 and an ultrafiltration rate above 750 mL in 24 hours.
♦ Setting
The study is being conducted in 26 dialysis centers in 13 European countries.
♦ Baseline Data Collection
The information collected includes patient demographics, dialysis prescription, achieved weekly creatinine clearance, and 24-hour ultra-filtration (UF).
♦ Results
The study enrolled 177 anuric patients. Median dialysis duration before enrollment was 22.5 months (range: 0 – 285 months). Mean solute transport measured as the dialysate-to-plasma ratio of creatinine (D/PCr) was 0.74 ± 0.12. Patients received APD for a median of 9.0 hours overnight (range: 7 – 12 hours) using a median of 11.0 L of fluid (range: 6 – 28.75 L). Median daytime volume was 4.0 L (range: 0.0 – 9.0 L). Tidal dialysis was used in 26 patients, and icodextrin in 86 patients. At baseline, before treatment optimization, the weekly mean total creatinine clearance was 65.2 ± 14.4 L/1.73 m2, with 105 patients (60%) achieving the target of more than 60 L/1.73 m2. At baseline, 81% of patients with high transport, 69% with high-average transport, and 40% with low-average transport met the target. At baseline, 70% of patients with a body surface area (BSA) below 1.7 m2, 60% with a BSA of 1.7 – 2.0 m2, and 56% with a BSA above 2.0 m2 achieved 60 L/1.73 m2 weekly. Median UF was 1090 mL/24 h, and 75% of patients achieved the UF target of more than 750 mL/24 h.
♦ Conclusion
This baseline analysis of anuric patients recruited into the EAPOS study demonstrates that a high proportion of anuric patients on APD can achieve dialysis and ultrafiltration targets using a variety of regimes. This 2-year follow-up study aims to optimize APD prescription to reach predefined clearance and ultrafiltration targets, and to observe the resulting clinical outcomes.
ChurchillD.N., TaylorD.W., KeshaviahP.R., and the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes.J Am Soc Nephrol1996; 7: 198–207.
2.
DaviesS.J., PhillipsL., GriffithsA.M., RussellL.H., NaishP.F., RussellG.I.What really happens to people on long-term peritoneal dialysis?Kidney Int1998; 54: 2207–17.
3.
JagerK.J., MerkusM.P., DekkerF.W., BoeschotenE.W., TijssenJ.G., StevensP.Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group.Kidney Int1999; 55(4): 1476–85.
4.
National Kidney Foundation.NKF–DOQI clinical practice guidelines for peritoneal dialysis adequacy.Am J Kidney Dis1997; 30(3 Suppl 2): S67–136.
5.
Treatment of adult patients with renal failure: recommended standards and audit measures.The Standards and Audit Subcommittee of the Renal Association on behalf of the Renal Association and the Royal College of Physicians.J R Coll Physicians Lond1995; 29(3): 190–1.
6.
MisraM., VoneshE., ChurchillD.N., MooreH.L., Van StoneJ.C., NolphK.D.A.Preservation of glomerular filtration rate on dialysis when adjusted for patient dropout.Kidney Int2000; 57(2): 691–6.
7.
MerkusM.P., JagerK.J., DekkerF.W., de HaanR.J., BoeschotenE.W., KredietR.T.Predictors of poor outcome in chronic dialysis patients: the Netherlands Cooperative Study on the Adequacy of Dialysis. the NECOSAD Study Group.Am J Kidney Dis2000; 35(1): 69–79.
8.
ChurchillD.N., ThorpeK.E., NolphK.D.A., KeshaviahP.R., OreopoulosD.G., PagéD.Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients.J Am Soc Nephrol1998; 9: 1285–92.
9.
DaviesS.J., PhillipsL., RussellG.I.Peritoneal solute transport predicts survival on CAPD independently of residual renal function.Nephrol Dial Transplant1998; 13(4): 962–8.
10.
PosthumaN., ter WeeP.M., VerbrughH.A., OeP.L., PeersE., SayersJ.Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24–h dialysate creatinine clearance.Nephrol Dial Transplant1997; 12(3): 550–3.
11.
VoneshE.F., StoryK.O., O'NeillW.T.A multinational clinical validation study of PD Adequest 2.0. PD Adequest International Study Group.Perit Dial Int1999; 19(6): 556–71.
